DiMi Telematics International, Inc. DIMI
We are adding DIMI to our radar this morning, as a possible dead-cat bounceplay. We always like to find stocks that have recently taken a beating, and attempt to anticipate resulting bounces.
Watching the level 2 late in the day yesterday, we noticed support building in the .07-range, and saw the stock trading heavily at .08 into the close.
We will of course be exercising extreme caution, but the potential for a recovery surge is pronounced, and thus we will want to keep a close eye for any possible gains.
Somaxon Pharmaceuticals, Inc. SOMX
We wanted to give a nod to SOMX this morning, as a stock that recently enjoyed a surge on extremely positive press.
It appears as if the surge could continue, as the stock seems to be gapping up this morning, so we will keep an eye peeled for that occurance.
SAN DIEGO, Jul 17, 2012 (GlobeNewswire via COMTEX) — Somaxon Pharmaceuticals, Inc. (Nasdaq:SOMX), a specialty pharmaceutical company, today announced that it has entered into separate settlement arrangements with Mylan Inc. and its subsidiary, Mylan Pharmaceuticals, Inc. and Par Pharmaceutical Companies, Inc. and its subsidiary Par Pharmaceutical, Inc. to resolve pending patent litigation involving Silenor(R) 3 mg and 6 mg tablets.
- Somaxon keeps insomnia drug exclusivity till 2020 at Reuters (Tue, Jul 17)
- UPDATE 1-Somaxon keeps insomnia drug exclusivity till 2020 at Reuters (Tue, Jul 17)